ABSTRACT To determine whether verapamil prevents depletion of adenine nucleotides during and after severe myocardial ischemia, dogs were subjected to 15 min occlusions of the left anterior descending coronary artery followed by 240 min of reperfusion. One hour before occlusion, dogs were randomly assigned to a treatment group (n = 10) to which an infusion of intravenous verapamil was given until the onset of reperfusion or to an untreated saline group (n = 9). Verapamil reduced mean aortic pressure and heart rate. After 15 min of ischemia, endocardial adenosine triphosphate (ATP) level, determined by needle biopsy, decreased in the untreated group from 34.7 + 2.0 to 24.4 + 2.7 nmol-mg protein-' (p < .005 vs preocclusion) and in the verapamil group from 32.8 + 1.5 to 30.3 + 1.5 nmol.mg protein-' (NS vs preocclusion). Dogs receiving verapamil had significantly higher ATP levels than untreated animals after 90 and 240 min of reperfusion. In untreated animals the sum of inosine and hypoxanthine levels increased during occlusion from very low levels to 4.6 + 1. 1 nmol mg protein-' in the epicardium and to 6.8 1.5 nmol.mg protein-' in the endocardium (p < .05 compared with preocclusion values). In verapamil-treated dogs inosine and hypoxanthine levels increased to only 1.2 ± 0.3 (epicardium) and 1.9 + 0.6 nmol.mg protein-' (endocardium) (both NS compared with preocclusion values). After 90 min of reperfusion the sum of ATP, adenosine diphosphate, adenosine monophosphate, inosine, and hypoxanthine levels was decreased in the endocardium by 10.2 nmolPmg protein-' in the untreated group, but no change was observed in verapamil-treated animals. We conclude that breakdown of ATP to inosine and hypoxanthine during severe ischemia is reduced by verapamil, resulting in higher ATP concentrations during occlusion and reperfusion and decreased washout of the diffusible purines inosine and hypoxanthine during reperfusion. Circulation 70, No. 4, 734-741, 1984. REPERFUSION after a brief period of coronary arterial occlusion (not long enough to cause myocardial infarction) does not result in an immediate recovery of cardiac function or metabolism, and this phenomenon has been referred to as "stunning of the myocardium. '1 1-0 In an effort to accelerate postischemic recovery from myocardial infarction, attention has been focused on restoration of adenosine triphosphate (ATP) content. Although the relationship between postischemic recovery and rate of ATP synthesis and degradation remains to be fully defined, restoration of myocar-
REPERFUSION after a brief period of coronary arterial occlusion (not long enough to cause myocardial infarction) does not result in an immediate recovery of cardiac function or metabolism, and this phenomenon has been referred to as "stunning of the myocardium. '1 1-0 In an effort to accelerate postischemic recovery from myocardial infarction, attention has been focused on restoration of adenosine triphosphate (ATP) content. Although the relationship between postischemic recovery and rate of ATP synthesis and degrada-dial function shows some correlation with the quantity of available high-energy phosphates.'1 During ischemia, ATP undergoes degradation to hypoxanthine (figure 1). During reperfusion, resynthesis of ATP occurs ( 1) by rephosphorylation of remaining adenosine diphosphate (ADP) via oxidative phosphorylation and glycolysis, (2) by use of preformed nucleotides, nucleosides, and bases in the so-called salvage pathway, and (3) by synthesis of new purine compounds from glycine, aspartate, glutamine, and formate via the de novo pathway. Delayed restoration of ATP stores after transient periods of ischemia is in part the result of depletion of the purine pool by washout of the membrane-permeable purines, namely, adenosine, inosine, and hypoxanthine.'2-15 Since ATP resynthesis would then depend on the de novo pathway, a process known to be slow,2 attempts have been made to replete tissue preserve ATP by pharmacologic intervention before and during the period of ischemia. In this study the possibility that the calcium antagonist verapamil reduces ATP degradation during ischemia was tested.
Methods
Twenty-five mongrel dogs* were anesthetized with sodium pentobarbital (30 mgtkg-'), intubated, and placed on a Harvard respirator. A thoracotomy was performed on each and the left anterior descending coronary artery (LAD) was isolated just proximal to the first diagonal approximately 2 cm from its origin. A polyethylene catheter was placed in the left atrium via the left atrial appendage and catheters were placed in the left femoral artery and femoral or jugular vein. The arterial line was connected to a Statham P23Db pressure transducer to measure aortic pressure.
Dogs were randomly assigned to an untreated or verapamiltreated group by drawing lots. Verapamil, 0.2 mg kg.' was administered intravenously as a bolus 45 to 60 min before occlusion, followed by a continuous infusion of 0.6 mg kg-' hr-l; untreated dogs received saline. The LAD was occluded with a Schwartz atraumatic vascular clamp for 15 min. On release of the coronary occlusion, the verapamil infusion was discontinued and reperfusion was carried out for a total of 240 min. Lidocaine (1.5 mg-kg-') was given intravenously to all dogs before occlusion and again during occlusion before reperfusion. Additional anesthesia with small doses of sodium pentobarbital were sometimes given as required during the latter half of the study. Regional myocardial blood flow was measured at the end of occlusion before biopsy and at 90 and 240 min of reperfusion by the radioactive microsphere technique. After the dogs were killed, specimens for determination of RMBF were dissected from the central ischemic zone (zone A) and the nonischemic zone (zone B) and divided into epicardium and endocardium. 
Results
Twenty-five dogs were entered into the study. Five dogs (four untreated, one treated) developed ventricular fibrillation and were eliminated: in one of these fibrillation was observed before occlusion, in one during occlusion, and in three during reperfusion. One dog died due to failure of the respirator. Thus, the final analysis was performed on data from nine untreated and 10 treated dogs.
Myocardial blood flow (table 1) . Endocardial blood flow during occlusion was reduced to the same extent in untreated (0. 19 ± 0.06 ml.min-l g-1) and treated (0.14 + 0.06 ml.min-'g) dogs. Flow in the nonischemic zone during occlusion was not significantly different in verapamil-treated and untreated animals. After 90 and 240 min of reperfusion endocardial flow in the central ischemic zone had recovered incompletely in both untreated and verapamil-treated groups and remained significantly lower than endocardial flow in the nonischemic zone, as tested by analysis of variance (p < .005). Thus, despite the brief period of ischemia, blood flow failed to return to normal in the previously ischemic, reperfused subendocardium. Blood flow to the ischemic and nonischemic endocardium and epicardium 15 min after the occlusion and 90 and 240 min after reperfusion were similar in verapamil-treated and untreated dogs. Thus, any differences in biochemical parameters between groups could not be explained by differences in regional flow.
Hemodynamic data (figure 2). Heart rate in treated dogs decreased by 18% from 138 + 11 beats/min before treatment to 1 13 ± 7 beats/min after treatment, i.e., just before occlusion (p < .001), and remained depressed throughout the occlusion and reperfusion periods (p < .001 compared with pretreatment). Likewise, systolic aortic pressure decreased from 135 ± 7 mm Hg before treatment to 107 ± 7 mm Hg after treatment (p < .0001) and to 101 ± 6 mm Hg during 'mg protein-' ). In the epicardium, ATP level was also higher in treated than in untreated dogs, but the difference did not reach statistical significance. During occlusion ADP values increased similarly in both groups by about 1.5 nmol-mg protein-', while changes in AMP were even smaller.
During occlusion, the sum of adenine nucleotides, E (ATP + ADP + AMP), decreased in untreated animals by 9.8 nmolmg protein' (epicardium) and 10.0 nmolbmg protein-' (endocardium) (p < .005 compared with preocclusion value), primarily because of the reduction in ATP. In the treated group the small decreases in the total adenine nucleotide content observed during occlusion were not significant (3.1 nmol.mg protein-' in the epicardium and 1.4 nmol.mg protein`in the endocardium) (p = NS vs preocclusion), primarily because the observed decrease in ATP content was compensated for by an increase in ADP ( figure 3, top) figure 3, center) .
Although the relative distribution of nucleotides, nucleosides, and bases was different during occlusion in untreated and treated animals, the sum of the primary purines in the ATP degradation pathway, i.e., E (ATP + ADP + AMP + inosine + hypoxanthine), was not significantly different between groups during the period of ischemia or compared with preocclusion values ( figure 3, bottom) . Hence, no net loss of purines occurred in either group during occlusion. Levels of the other major nucleotides present in heart were also measured. During occlusion, the pu- tion of the pyridine nucleotide NAD + in either group. Levels of phosphocreatine, a major high-energy phosphate compound in heart, decreased in both groups in the epicardium and endocardium (table 3) .
Response to reperfusion. ATP levels at 90 and 240 min of reperfusion were not different from the values obtained at the end of the occlusion period in either group. Endocardial ATP concentration remained significantly higher in treated compared with untreated dogs at 90 and 240 min after reperfusion (p < .005; figure 3, bottom) . This finding indicates that the net loss of purine compounds in the untreated group occurred early during reperfusion. In contrast, in verapamil-treated animals, total purine content did not change during reperfusion.
Endocardial GTP values were significantly lower than before occlusion at 90 and 240 min of reperfusion in untreated animals and at 240 min of reperfusion in treated animals. Phosphocreatine content was completely restored during reperfusion both in untreated and treated dogs ( '6 In globally hypoxic isolated rabbit hearts, Nayler et al.37 observed that verapamil reduced myocardial uptake of Na+ and loss of K+, slowed the rate of creatine kinase release, and decreased ATP and phosphocreatine breakdown. The present study expands existing knowledge in that it shows that verapamil has beneficial effects in a preparation of regional ischemia in vivo (occlusion followed by reperfusion) in which levels of high-energy phosphate compounds are assessed by serial biopsies. It also shows that ATP is specifically preserved both during occlusion and reperfusion periods. The content of ATP and its major catabolites in myocardium decrease in untreated animals, while treated dogs exhibit no change.
The mechanism by which verapamil preserves ATP content is not clear, but given that ATP is specifically protected, it seems likely that the mechanism involves ATP synthesis and/or utilization. In previous studies in our laboratory carried out in open-chest dogs subjected to 1 hr of ischemia, it was observed that verapamil caused a marked reduction in ultrastructural damage with striking preservation of the mitrochondrial ultrastructure. 38 
